{"schema_version":"secwatch.filing_event.v1","accession":"0001425203-21-000002","form_type":"8-K","ticker":"VNOV","cik":"0001699709","company_name":"VitaNova Life Sciences Corp","filed_at":"2021-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.266981+00:00","generated_at":"2026-06-29T21:48:33.478061+00:00","sec_items":["5.01","5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Barry Sytner acquires 86.3% of Yijia Group, becomes CEO; previous officers resign","bullets":["Barry Sytner purchased 5,066,250 common shares from officers/directors and majority shareholders on July 28, 2021.","The shares represent 86.3% of outstanding common stock, effective August 4, 2021, resulting in a change of control.","Shaoyin Wu, Kim Lee Poh, and Jian Yang resigned as officers and directors on July 28, 2021.","Barry Sytner, age 68, appointed CEO and Director; has over 40 years of business experience.","New management intends to pursue business consulting."],"urls":{"canonical":"https://secwatch.observer/filing/0001425203-21-000002","json":"https://secwatch.observer/filing/0001425203-21-000002.json","markdown":"https://secwatch.observer/filing/0001425203-21-000002.md","text":"https://secwatch.observer/filing/0001425203-21-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699709/000142520321000002/0001425203-21-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699709/000142520321000002/yjgjform8kdated8521items5015.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T21:48:33.478061+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01f8fc452a","claim":"Kim Lee Poh resigned as officer and director at VitaNova Life Sciences Corp.","evidence_excerpt":"On July 28, 2021, Shaoyin Wu, Kim Lee Poh and Jian Yang resigned as officers and directors of the registrant.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1699709/000142520321000002/0001425203-21-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"officer and director"}],"fact_type":"executive_change"},{"claim_id":"0e89c6de14","claim":"Jian Yang resigned as officer and director at VitaNova Life Sciences Corp.","evidence_excerpt":"On July 28, 2021, Shaoyin Wu, Kim Lee Poh and Jian Yang resigned as officers and directors of the registrant.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1699709/000142520321000002/0001425203-21-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"officer and director"}],"fact_type":"executive_change"},{"claim_id":"1b3290d94d","claim":"Barry Sytner was appointed as Chief Executive Officer and Director at VitaNova Life Sciences Corp.","evidence_excerpt":"On July 28, 2021, Barry Sytner, age 68, was appointed as Chief Executive Officer and Director of the registrant.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1699709/000142520321000002/0001425203-21-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer and Director"}],"fact_type":"executive_change"},{"claim_id":"53828c5d0b","claim":"Shaoyin Wu resigned as officer and director at VitaNova Life Sciences Corp.","evidence_excerpt":"On July 28, 2021, Shaoyin Wu, Kim Lee Poh and Jian Yang resigned as officers and directors of the registrant.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1699709/000142520321000002/0001425203-21-000002-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"officer and director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}